4//SEC Filing
Iannone Robert 4
Accession 0001784606-24-000008
CIK 0001232524other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:25 PM ET
Size
6.8 KB
Accession
0001784606-24-000008
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Award
Ordinary Shares
2024-01-17+5,970→ 51,322 total - Tax Payment
Ordinary Shares
2024-01-17$119.13/sh−1,730$206,095→ 49,592 total
Footnotes (3)
- [F1]Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.
- [F2]The Reporting Person acquired 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023.
- [F3]Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001737329
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 6:25 PM ET
- Size
- 6.8 KB